Rate or rhythm control for atrial fibrillation: Update and controversies

American Journal of Medicine

Volumn 125, Issue 11, 2012, Pages 1049-1056

  Chinitz, Jason S ^a   Halperin, Jonathan L ^a   Reddy, Vivek Y ^a   Fuster, Valentin ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Ablation; Antiarrhythmic drugs; Atrial fibrillation; Rate control; Rhythm control

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; FLECAINIDE; PLACEBO; PROPAFENONE; SOTALOL;

ADVERSE OUTCOME; ANGINA PECTORIS; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG TOLERABILITY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART RHYTHM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; ISCHEMIC HEART DISEASE; LIVER TOXICITY; LONG TERM CARE; LUNG TOXICITY; PARANEOPLASTIC NEUROPATHY; PHOTOSENSITIVITY DISORDER; POLYNEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SINUS BRADYCARDIA; SINUS RHYTHM; SURVIVAL; THYROID DISEASE; THYROTOXICOSIS; TORSADE DES POINTES; URINE RETENTION; VISUAL DISORDER;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DISEASE MANAGEMENT; HEART RATE; HUMANS;

EID: 84867869976     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.04.007     Document Type: Review

References (40)

1. A.D. Krahn, J. Manfreda, R.B. Tate, F.A. Mathewson, T.E. Cuddy The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study Am J Med 98 1995 476 484
2. P.A. Wolf, R.D. Abbott, W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
3. P. Dorian, M. Paquette, D. Newman Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation Am Heart J 143 2002 984 990
4. J.Y. Le Heuzey, O. Paziaud, O. Piot Cost of care distribution in atrial fibrillation patients: the COCAF study Am Heart J 147 2004 121 126
5. T.J. Bunch, J.P. Weiss, B.G. Crandall Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia Heart Rhythm 7 2010 433 437
6. A.P. Maggioni, R. Latini, P.E. Carson Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT) Am Heart J 149 2005 548 557
7. D.G. Wyse, A.L. Waldo, J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
8. I.C. Van Gelder, V.E. Hagens, H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
9. S.H. Hohnloser, K.H. Kuck, J. Lilienthal Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
10. G. Opolski, A. Torbicki, D.A. Kosior Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study Chest 126 2004 476 486
11. J. Carlsson, S. Miketic, J. Windeler Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
12. D. Roy, M. Talajic, S. Nattel Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
13. S.D. Corley, A.E. Epstein, J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
14. D.J. Wilber, C. Pappone, P. Neuzil Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
15. R.J. Hunter, J. McCready, I. Diab Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death Heart 98 2012 48 53
16. R. Cappato, H. Calkins, S.A. Chen Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circ Arrhythm Electrophysiol 3 2010 32 38
17. O.M. Wazni, N.F. Marrouche, D.O. Martin Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640
18. L.S. Wann, A.B. Curtis, C.T. January 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 223 242
19. L.F. Hsu, P. Jais, P. Sanders Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2004 2373 2383
20. A.J. Camm, P. Kirchhof, G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
21. H. Calkins, K.H. Kuck, R. Cappato 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696.e21
22. E. Ewen, P. Carita, L. Eckert A comparative analysis of cost and cost-effectiveness of rhythm vs rate control strategies in the treatment of atrial fibrillation patients Circulation 122 2010 A16188
23. W. Martin-Doyle, M.R. Reynolds Is AF ablation cost effective? J Atr Fibrillation 2 2010 727 739
24. P.S. Chan, S. Vijan, F. Morady, H. Oral Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation J Am Coll Cardiol 47 2006 2513 2520
25. P.R. Kowey, G. Breithardt, J. Camm Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey Clin Cardiol 33 2010 172 178
26. J.Y. Le Heuzey, G.M. De Ferrari, D. Radzik, M. Santini, J. Zhu, J.M. Davy A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
27. S.H. Hohnloser, H.J. Crijns, M. van Eickels Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
28. L. Kober, C. Torp-Pedersen, J.J. McMurray Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
29. S.J. Connolly, A.J. Camm, J.L. Halperin Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 365 2011 2268 2276
30. F. Buccelletti, P. Iacomini, G. Botta Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European Medicines Agency approval: systematic review and meta-analysis J Clin Pharmacol 2011 Dec 13 [Epub ahead of print]
31. C. Torp-Pedersen, D.H. Raev, G. Dickinson, N.N. Butterfield, B. Mangal, G.N. Beatch A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion Circ Arrhythm Electrophysiol 4 2011 637 643
32. Y.K. Iwasaki, K. Nishida, T. Kato, S. Nattel Atrial fibrillation pathophysiology: implications for management Circulation 124 2011 2264 2274
33. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
34. S. Nattel, P. Khairy, D. Roy New approaches to atrial fibrillation management: a critical review of a rapidly evolving field Drugs 62 2002 2377 2397
35. M.A. Wood Trials of pacing to control ventricular rate during atrial fibrillation J Interv Card Electrophysiol 10 Suppl 1 2004 63 70
36. R.N. Doshi, E.G. Daoud, C. Fellows Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) J Cardiovasc Electrophysiol 16 2005 1160 1165
37. B.D. Williamson, K.C. Man, E. Daoud, M. Niebauer, S.A. Strickberger, F. Morady Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation N Engl J Med 331 1994 910 917
38. J.Y. Le Heuzey, G. Breithardt, J. Camm The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 2010 687 693
39. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
40. C.B. de Vos, R. Pisters, R. Nieuwlaat Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis J Am Coll Cardiol 55 2010 725 731